Furosemide: Difference between revisions

(Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: Lasix ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Pregnancy Rating:...")
 
(added page)
Line 1: Line 1:
==General==
==General==
*Type:  
*Type: Diuretic
*Dosage Forms:
*Dosage Forms:20, 40, 80
*Common Trade Names: Lasix
*Common Trade Names: Lasix


==Adult Dosing==
==Adult Dosing==
 
*HTN: 10-40 mg PO QDAY-BID, max 600 mg/day
*Hypercalcemia: 120 mg/day PO divided QDAY - TID
==Pediatric Dosing==
==Pediatric Dosing==
 
* Hypercalcemia: 25-50 mg IV q4h
==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:C
*Lactation:
*Lactation: safety unknown
*Renal Dosing
*Renal Dosing
**Adult
**Adult: no adjustment, contraindicated in anuria
**Pediatric
**Pediatric: no adjustment, contraindicated in anuria
*Hepatic Dosing
*Hepatic Dosing
**Adult
**Adult: not defined
**Pediatric
**Pediatric: not defined


==Contraindications==
==Contraindications==
*Allergy to class/drug
*Allergy to class/drug
 
*anuria
*electrolyte imbalances
==Adverse Reactions==
==Adverse Reactions==
===Serious===
===Serious===
 
*hypokalemia
*metabolic alkalosis
*hypovolemia
*ototoxicity
*hemolytic anemia
*vasculitis
*steven-johnson syndrome
*pancreatitis
*eosinophilia
===Common===
===Common===
 
*urinary frequency
*dizziness
* nausea/vomiting
* weakness
*muscle cramping
*hypokalemia
*hypomagnesemia
*blurred vision
*diarrhea
*hyperglycemia
*hyperuricemia
*tinnitus
==Pharmacology==
==Pharmacology==
*Half-life:  
*Half-life: 30-60 min
*Metabolism:  
*Metabolism: liver minimally
*Excretion:  
*Excretion: urine
*Mechanism of Action:
*Mechanism of Action: inhibits loop of henle and proximal and distal convoluted tubule sodium and chloride resorption


==See Also==
==See Also==

Revision as of 10:00, 13 April 2015

General

  • Type: Diuretic
  • Dosage Forms:20, 40, 80
  • Common Trade Names: Lasix

Adult Dosing

  • HTN: 10-40 mg PO QDAY-BID, max 600 mg/day
  • Hypercalcemia: 120 mg/day PO divided QDAY - TID

Pediatric Dosing

  • Hypercalcemia: 25-50 mg IV q4h

Special Populations

  • Pregnancy Rating:C
  • Lactation: safety unknown
  • Renal Dosing
    • Adult: no adjustment, contraindicated in anuria
    • Pediatric: no adjustment, contraindicated in anuria
  • Hepatic Dosing
    • Adult: not defined
    • Pediatric: not defined

Contraindications

  • Allergy to class/drug
  • anuria
  • electrolyte imbalances

Adverse Reactions

Serious

  • hypokalemia
  • metabolic alkalosis
  • hypovolemia
  • ototoxicity
  • hemolytic anemia
  • vasculitis
  • steven-johnson syndrome
  • pancreatitis
  • eosinophilia

Common

  • urinary frequency
  • dizziness
  • nausea/vomiting
  • weakness
  • muscle cramping
  • hypokalemia
  • hypomagnesemia
  • blurred vision
  • diarrhea
  • hyperglycemia
  • hyperuricemia
  • tinnitus

Pharmacology

  • Half-life: 30-60 min
  • Metabolism: liver minimally
  • Excretion: urine
  • Mechanism of Action: inhibits loop of henle and proximal and distal convoluted tubule sodium and chloride resorption

See Also

Sources